These lab-designed alternatives weren't formulated with recreational use in mind. While in the nineteen nineties, John W. Huffman and a crew of fellow chemists at Clemson University designed some of the first formulation for artificial cannabinoid receptor agonists (SCRAs), a family members of substances that imitate the physiological and psycholog